微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 9.19% | 4.02% | -3.13% | 48/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 9.49% | 22.24% | 21.05% | 48/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 7.84% | -4.28% | -17.91% | 48/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 9.55% | 245.38% | 8.06% | 48/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 8.83% | 190.6% | 13.84% | 48/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 7.76% | 142.45% | -5.22% | 48/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 8.19% | 110.46% | 224.68% | 47/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | -6.57% | -541.83% | 32.66% | 50/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | -9.75% | -284.15% | 46.66% | 45/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | -18.28% | -415.96% | 76.65% | 49/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | -78.27% | -1044.1% | -5366.26% | 43/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 1.49% | 116.14% | -71.93% | 50/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 5.29% | 151.99% | -8.47% | 39/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 5.79% | 143.54% | -30.22% | 48/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 8.29% | 132.67% | 190.01% | 32/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | -9.21% | -164.36% | 9.57% | 49/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | -10.18% | -140.27% | 23.34% | 33/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | -13.29% | -149.97% | 47.65% | 40/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | -25.38% | -188.56% | -277.33% | 31/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 14.31% | -35.26% | -43.41% | 47/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 25.29% | 20.93% | -4.89% | 28/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 26.59% | 30.82% | -7.21% | 32/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 28.65% | 42.83% | 29.64% | 26/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 22.1% | 11.19% | 5.71% | 45/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 20.91% | 4.3% | 2.89% | 27/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 20.32% | 4.4% | 1.3% | 31/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 20.06% | 1.34% | 0.92% | 25/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 19.88% | -1.83% | -0.85% | 40/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 20.05% | -2.36% | 2.99% | 24/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 19.47% | -3.65% | -1.67% | 28/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 19.8% | -1.26% | -2.23% | 21/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 20.25% | 0.09% | -1.39% | 29/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 20.53% | 2.24% | 1.63% | 18/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 20.2% | 1.76% | 0.77% | 19/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 20.05% | 1.31% | -0.89% | 14/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 20.23% | -2.05% | 0.73% | 26/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 20.08% | -2.54% | 1.16% | 17/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 19.85% | -1.72% | 0.32% | 16/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 19.79% | -0.25% | -4.18% | 15/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |